<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8IN9RW7F/6c6036b7-9c15-475d-b8fa-b94035481068/HTML"><dcterms:extent>59 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8IN9RW7F/d0166098-454e-484d-b7e5-92e2c1c8d0ae/PDF"><dcterms:extent>993 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8IN9RW7F/7e4610ba-9426-4a2a-8039-4ff4dacf4302/TEXT"><dcterms:extent>34 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-8IN9RW7F"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2008</dcterms:issued><dc:creator>Strojan, Primož</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:42</dc:format><dc:format xml:lang="sl">str. 69-81</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:24489433</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-8IN9RW7F</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">biokemija</dc:subject><dc:subject xml:lang="en">Cathepsins</dc:subject><dc:subject xml:lang="sl">Cistatini</dc:subject><dc:subject xml:lang="en">Cystatins</dc:subject><dc:subject xml:lang="sl">glava</dc:subject><dc:subject xml:lang="sl">Glava in vrat, novotvorbe</dc:subject><dc:subject xml:lang="en">Head And Neck Neoplasms</dc:subject><dc:subject xml:lang="en">Immunohistochemistry</dc:subject><dc:subject xml:lang="sl">Imunohistokemija</dc:subject><dc:subject xml:lang="sl">Katepsini</dc:subject><dc:subject xml:lang="sl">novotvorbe</dc:subject><dc:subject xml:lang="sl">Preživetje, analiza</dc:subject><dc:subject xml:lang="en">Prognosis</dc:subject><dc:subject xml:lang="sl">Prognoza</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">stefini</dc:subject><dc:subject xml:lang="en">Survival Analysis</dc:subject><dc:subject xml:lang="en">tumor</dc:subject><dc:subject xml:lang="sl">vrat</dc:subject><dc:subject xml:lang="sl">Vrata</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Cysteine cathepsins and stefins in head and neck cancer| an update of clinical studies|</dc:title><dc:description xml:lang="sl">Background. Cancer of the head and neck represents a diverse group of malignant diseases; so far, no factor in a wide spectrum of biochemical and histological candidate-markers has yet been identified to predict reliably thenatural course of the disease or its response to the therapy to be used in routine clinical practice. Among the factors that promote tumor growth and invasion, several protease systems, implemented in proteolytic degradation of extracellular matrix components, were studied, including papain-like lysosomalcysteine proteases (e.g. cathepsins B and L) and their physiological inhibitors cystatins (e.g. stefins A and B, cystatin C). The aim of the present report is to review the published studies on clinical applicability ofcysteine cathepsins and their endogenous inhibitors stefins in squamous cellcarcinoma of the head and neck and to present recent research results fromthis area conducted jointly by the Institute of Oncology Ljubljana and ENTDepartment of the University Medical Center Ljubljana, Slovenia. Conclusions. According to our experience, immunohistochemical staining of cysteine cathepsins and stefins seems to be of limited value for predicting either treatment response or patientsć survival. However, the results of studies on stefin A in tumor tissue cytosols should be considered hypothesis-generating and deserves further evaluation in the frame of prospective controlled multicentric clinical study</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-8IN9RW7F"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-8IN9RW7F" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-8IN9RW7F/d0166098-454e-484d-b7e5-92e2c1c8d0ae/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-8IN9RW7F/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-8IN9RW7F" /></ore:Aggregation></rdf:RDF>